eduKateSG · Why Science?
Study healthy ageing without hype—connecting mechanisms, biomarkers, models, cohorts, function, interventions, trials, ethics and quality of life
A fact-checked guide to the NUS Medicine Healthy Longevity Translational Research Programme and the evidence needed to add healthy years responsibly.
The official NUS programme states a mission to add healthy years to life by delaying ageing, extending disease-free life and improving quality of life.
Its current themes include biology of ageing, muscle ageing, brain ageing, vascular ageing, regenerative medicine and reproductive longevity.
Did you know? A longer lifespan and a longer healthspan are different outcomes, so researchers must name which one they measure.
This guide makes no anti-ageing or treatment recommendation. NUS and qualified professionals control current research and care. Sources were checked 11 November 2026.
Chapter index
Chapters 1–9: healthy longevity, healthspan, biological age, senescence, stress resistance, mitochondria, metabolism, microbiome, muscle
Chapters 10–17: brain, vascular and reproductive ageing, biomarkers, cohorts, interventions, trials, equity and evidence receipts
Healthspan concerns years lived with good function and manageable disease burden. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 1 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Choose explicit functional and quality-of-life outcomes. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
Longer lifespan does not automatically mean better healthspan. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Define healthspan” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Compare four outcome definitions. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 1 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
People of the same calendar age can differ in molecular and functional measures. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 2 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Validate estimates against meaningful outcomes. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
An age clock is not a diagnosis. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Separate chronological and biological age” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Audit a fictional age claim. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 2 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
Some stressed cells enter lasting states that alter tissue signalling. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 3 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Measure markers, function and context together. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
No single marker identifies every senescent cell. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Study cellular senescence” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Build a multi-marker plan. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 3 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
Cells and organisms respond to heat, oxidation and nutrient change. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 4 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Control dose, timing and recovery. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
Laboratory stress may not represent ordinary ageing. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Measure stress resistance” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Plot a stress-response curve. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 4 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
| Evidence move | What to record | What it cannot prove alone |
|---|---|---|
| Definition question | Population, variable, unit and time window | A definition does not establish a result |
| Comparison | Baseline, comparator and uncertainty | Association alone does not establish cause |
| Decision boundary | Owner, trigger, review and escalation | A model does not replace accountable judgement |
Energy production, signalling and fuel use change across tissues. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 5 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Combine molecular measures with function. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
A difference may be cause, response or compensation. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Examine mitochondria and metabolism” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Map competing explanations. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 5 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
Microbial communities interact with diet, immunity, medicines and environment. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 6 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Use longitudinal sampling and metadata. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
Association does not prove one microbe controls ageing. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Include the microbiome” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Design a confounder checklist. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 6 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
Strength, mass, neural control and activity shape mobility. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 7 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Measure composition and function. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
One test cannot explain every limitation. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Study muscle ageing” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Compare strength, power and endurance. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 7 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
Cognition reflects networks, health, experience, sleep and environment. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 8 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Use repeated appropriate measures and imaging cautiously. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
A group average does not predict an individual course. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Study brain ageing” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Design a longitudinal chart. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 8 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
| Evidence move | What to record | What it cannot prove alone |
|---|---|---|
| Mechanism question | Population, variable, unit and time window | A definition does not establish a result |
| Comparison | Baseline, comparator and uncertainty | Association alone does not establish cause |
| Decision boundary | Owner, trigger, review and escalation | A model does not replace accountable judgement |
Vessels change in structure, elasticity and signalling. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 9 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Combine physiology, imaging and molecular evidence. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
One stiffness measure is not the whole system. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Study vascular ageing” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Create an evidence ladder. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 9 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
Reproductive tissues and endocrine systems have distinct trajectories. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 10 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Define outcomes, stages and context precisely. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
A timeline does not define a person’s value or choices. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Study reproductive longevity” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Write respectful definitions. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 10 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
Cells, invertebrates, fish and rodents reveal different mechanisms. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 11 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Match conservation and limits to the hypothesis. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
Model lifespan extension does not prove human benefit. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Choose ageing models” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Build a translation matrix. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 11 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
Biomarkers may estimate state, pace, response or risk. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 12 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Test repeatability, validity and change. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
A younger marker may not improve function. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Develop ageing biomarkers” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Compare surrogate and clinical outcomes. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 12 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
| Evidence move | What to record | What it cannot prove alone |
|---|---|---|
| Translation question | Population, variable, unit and time window | A definition does not establish a result |
| Comparison | Baseline, comparator and uncertainty | Association alone does not establish cause |
| Decision boundary | Owner, trigger, review and escalation | A model does not replace accountable judgement |
Repeated observation reveals trajectories and transitions. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 13 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Track attrition and changing exposures. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
Survivor bias can distort later groups. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Build longitudinal cohorts” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Model fictional attrition. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 13 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
Sleep, activity, nutrition and social context influence health. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 14 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Use feasible comparators and relevant outcomes. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
Population evidence is not personal prescription. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Evaluate lifestyle interventions” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Design a pragmatic outline. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 14 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
Compounds may target pathways linked to ageing mechanisms. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 15 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Move through preclinical evidence, dose, safety and trials. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
Mechanistic promise is not net benefit. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Evaluate candidate therapeutics” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Draw a translational gate. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 15 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
Longevity research affects consent, access and social priorities. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 16 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Include diverse participants and distributional outcomes. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
Technology can widen inequality. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Protect ethics and equity” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Create an equity review. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 16 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
The receipt links definition, model, biomarker, intervention and outcome. Healthy longevity research asks how people might spend more years in good function and which biological processes, environments and interventions influence that trajectory. The NUS programme combines fundamental, computational and clinical approaches. Chapter 17 separates lifespan, healthspan, disease-free time and functional ability so a promising result cannot hide behind an ambiguous phrase such as “anti-ageing”.
Archive protocols, batches, attrition and adverse events. A careful study states the model, age range, sex, tissue, exposure, outcome, follow-up period and comparison. Researchers distinguish chronological age from biological estimates, validate assays, track attrition and ask whether change is larger than measurement noise. Longitudinal evidence is especially useful because ageing unfolds over time rather than appearing in one snapshot.
Documentation cannot turn a surrogate into benefit. Preserve the model-to-human boundary. A pathway that extends life in a cell, worm, fish or mouse can teach mechanism without establishing safety or benefit in people. A biomarker may correlate with age yet fail to respond meaningfully to intervention. Human claims need ethical trials, relevant outcomes, adverse-event monitoring and enough follow-up to observe benefit and harm.
Explore “Keep a longevity evidence receipt” using a fictional cohort table or a safe model. Define the outcome, graph change over time, identify missing observations and write one result sentence with one limitation. Assemble a one-page receipt. Do not recommend supplements, fasting, medicine or exercise changes from the activity; individual health decisions belong with qualified professionals.
Did you know? An intervention can improve one laboratory marker while leaving strength, cognition or daily function unchanged. Chapter 17 explains why healthy-longevity science uses several layers of evidence and why outcomes that matter to people remain central. The most useful scientific result may be a clearer next experiment instead of a premature promise.
Capabilities span cell biology, physiology, neuroscience, epidemiology, statistics, bioinformatics, rehabilitation, public health and ethics. They can support study and work across research, healthcare and policy, subject to current qualifications. Learners can begin with precise definitions, fair comparisons, uncertainty and respect for older people as partners in research rather than data points.
| Evidence move | What to record | What it cannot prove alone |
|---|---|---|
| Longevity question | Population, variable, unit and time window | A definition does not establish a result |
| Comparison | Baseline, comparator and uncertainty | Association alone does not establish cause |
| Decision boundary | Owner, trigger, review and escalation | A model does not replace accountable judgement |
Contents · Previous chapter · Continue in the Science Learning Hub
Primary sources and verification date
Source status for Why Science? | Healthy Longevity Translational Research Programme was checked 11 November 2026. Research priorities, programmes, recruitment, facilities and participation routes can change; use the linked official owner for the current edition.
- NUS Healthy Longevity TRP — Official vision, mission and themes.
- Healthy Longevity overview — Official programme strategy.
- Healthy Longevity research themes — Official theme descriptions.
- NUS Medicine research programmes — Official programme listing.
Continue the evidence journey
Healthy longevity science is strongest when it defines the outcome, follows evidence across models and people, measures function and resists premature promises. Families considering science tuition or a science tutor can use the same evidence questions: what will the learner practise, what feedback will they receive, and how will progress be shown?